(2018-05-02) 16 Pitfalls To Avoid When Building A Computational Therapeutics Company

16 Pitfalls to Avoid When Building a Computational Therapeutics Company

While the early signals of progress for traditional tech companies are fairly well known — product, customers, revenue — biotech companies operate under a very different timeline, metrics, and milestones.

healthcare startups can experience initial success that then slows to a halt once they realize the difficulty of translating their value through well-established processes and criteria.

below are 16 common pitfalls to avoid when creating therapeutics companies at the intersection of technology and biology.

#1 Starting as a service

service agreements — or are so back-loaded that the company will maybe see a small payout in 15 years if the drug becomes a big commercial success.